Foresee Pharmaceuticals Co., Ltd. Stock price
Equities
6576
TW0006576002
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
97.8 TWD | -0.20% | +2.95% | +1.66% |
Sales 2023 | 195M 6.1M | Sales 2024 * | 916M 28.67M | Capitalization | 13.31B 416M |
---|---|---|---|---|---|
Net income 2023 | -1.04B -32.43M | Net income 2024 * | -76M -2.38M | EV / Sales 2023 | 67 x |
Net Debt 2023 * | 45M 1.41M | Net Debt 2024 * | 116M 3.63M | EV / Sales 2024 * | 14.7 x |
P/E ratio 2023 |
-11.8
x | P/E ratio 2024 * |
-153
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 66.81% |
1 day | -0.20% | ||
1 week | +2.95% | ||
Current month | -7.30% | ||
1 month | -5.51% | ||
3 months | +1.66% | ||
6 months | +21.79% | ||
Current year | +1.66% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Hua Li
FOU | Founder | - | 15-07-08 |
Benjamin Chien
CEO | Chief Executive Officer | - | 13-02-07 |
Max Chan
DFI | Director of Finance/CFO | 56 | 19-10-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lee
BRD | Director/Board Member | 73 | 15-08-02 |
Benjamin Chien
CEO | Chief Executive Officer | - | 13-02-07 |
Fu Shiow Yin
BRD | Director/Board Member | - | 16-03-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 36 M€ | +4.92% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 97.8 | -0.20% | 163,768 |
24-03-27 | 98 | +1.45% | 193,412 |
24-03-26 | 96.6 | -0.31% | 134,735 |
24-03-25 | 96.9 | +1.47% | 161,776 |
24-03-22 | 95.5 | +0.53% | 148,773 |
End-of-day quote Taipei Exchange, March 27, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.66% | 415M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
-8.77% | 11.06B |